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Background: Type 1 diabetes mellitus (T1DM) is associated with cerebral compromise, typically found in patients
with microangiopathy. Associations between subclinical macroangiopathy and the brain, whether or not in the
presence of microangiopathy, have not been fully explored in T1DM. We hypothesized that subclinical
macroangiopathy in adult T1DM may affect the brain and interacts with microangiopathy.
Methods: In 51 asymptomatic T1DM patients with, 53 without proliferative retinopathy and 51 controls, right
common carotid artery ultrasound was used to assess intima media thickness (cIMT) and distensibility (cD).
Neuropsychological tests for cognitive functions, and magnetic resonance imagining for white matter integrity and
functional connectivity, i.e. neuronal communication, were used.
Results: After correction for confounders, cIMT was borderline significantly increased in all T1DM patients (P = 0.071),
whereas cD was not statistically significantly altered (P = 0.45). Patients with proliferative retinopathy showed the
largest increase in cIMT and decrease in cD. In all participants, after adjustment for confounders, increased cIMT was
related to decreased white matter integrity (β = −0.198 P = 0.041) and decreased functional connectivity in visual areas
(β = −0.195 P = 0.046). For cognition, there was a significant interaction between cIMT and the presence of proliferative
retinopathy after adjustment for confounding factors (all P < 0.05). Increased cIMT was associated with lower general
cognitive ability (β = −0.334; P = 0.018), information processing speed (β = −0.361; P = 0.010) and attention (β = −0.394;
P = 0.005) scores in patients without, but not in patients with proliferative retinopathy.
Conclusions: These findings suggest that subclinical macroangiopathy may be a factor in the development of
diabetes-related cognitive changes in uncomplicated T1DM, whereas in patients with advanced T1DM, proliferative
retinopathy may rather be the driving force of cerebral compromise.
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Over the last decade, evidence has accumulated showing
that adult type 1 diabetes mellitus (T1DM) is associated
with decrements in mental efficiency [1]. These changes
are accompanied by structural and functional cerebral
compromise, including loss of white matter tract integ-
rity and altered functional connectivity, i.e. neuronal
communication [2-4]. Both white matter tract integrity
and functional connectivity were shown to associate with
cognitive functions in T1DM patients [2-4]. These alter-
ations in the cerebrum are typically seen in patients with
peripheral complications such as proliferative retinop-
athy, which is considered to be a consequence or marker
of chronic hyperglycemia [5,6]. Proliferative retinopathy
is hypothesized to be a good marker for T1DM related
brain damage, as the retina shares similar anatomical
and physiological features with the brain, to which it is
embryologically linked [7].
Besides microangiopathy, macrovascular changes are
a common finding in T1DM, even in asymptomatic pa-
tients. Cross-sectional studies observed increased com-
mon carotid Intima Media Thickness (cIMT) in T1DM
adolescents and adults as compared with controls [8,9].
Associations of cIMT and alterations in the cerebrum
have been reported in patients with type 2 diabetes and
in a population-based study [10,11]. To date, studies on
the relation of cIMT and cerebral compromise in
T1DM patients are scarce. In the DCCT/EDIC, cIMT
predicted decline in psychomotor speed over 18 years,
but this association was of borderline significance after
strict correction for multiple comparisons [5]. No
T1DM studies hitherto have linked cIMT to cerebral
structural and functional connectivity. Carotid distensi-
bility (cD), as a measure of arterial stiffness, has also
not yet been assessed in T1DM in relation to brain
functioning.
It may be speculated that subclinical macroangiopathy
negatively impacts the brain in T1DM, and that it may
aggravate the effect of proliferative retinopathy on the
brain. Therefore we investigated differences of subclin-
ical macroangiopathy between healthy controls and
T1DM patients with and without proliferative retinop-
athy. Second, associations between subclinical macroan-
giopathy and cognitive, white matter tract integrity and
functional connectivity parameters were calculated in
these participants. Last, to address the hypothesis that
subclinical macroangiopathy may aggravate the effect of
proliferative retinopathy on the brain, we tested whether
the interaction terms of subclinical macroangiopathy
with proliferative retinopathy were statistically significant
for the brain measurements. Such significant interactions
indicate that the effect of subclinical macroangiopathy dif-
fers according to proliferative retinopathy status, which
was subsequently tested.Methods
Participants
Fifty-one T1DM patients with proliferative retinopathy,
53 T1DM patients without proliferative retinopathy and
51 controls matched for gender, body mass index (BMI)
and estimated IQ were included in this study. A detailed
description of the study design can be found elsewhere
[4]. In short, participants were eligible when between
18–56 years of age, right-handed, proficient in Dutch,
and in case of T1DM patients, a disease duration of
at least 10 years. Participants were excluded in the pres-
ence of BMI above 35 kg/m2, alcohol or drug abuse,
psychiatric comorbidity warranting treatment, centrally
acting medication use, cardio- or cerebrovascular dis-
ease, head trauma, hepatitis, anaemia, thyroid dysfunc-
tion, pregnancy, epilepsy, contraindication for MRI or
insufficient visual acuity to perform the neuropsycho-
logical tests. Additionally, controls were excluded in case
of hypertension. Patients with proliferative retinopathy
(ascertained by fundus photography and rated according
to the EURODIAB classification [12] by a trained oph-
thalmologist [ACM]) could also have microalbuminuria
(ascertained by 24-hour urine albumin:creatinine ratio
>2.5 mg/mmol for men and >3.5 mg/mmol for women)
or peripheral (poli)neuropathy (based on the annual
clinical check-up patients receive, which is incorporated
into the medical records, or self-report if not available
[4]). Patients without proliferative retinopathy had to be
free of clinically detectable microvascular complications.
During the study blood glucose was actively kept be-
tween 4–15 mmol/l, hypoglycemia 24-hours prior to
testing lead to rescheduling. In case of hyperglycemia,
patients were instructed to inject 2 units of the partici-
pants’ current rapid-acting insulin analog when blood
glucose levels were between 15 and 20 mmol/l and 4
units when glucose levels exceeded 20 mmol/l. In case
of hypoglycemia, participants were instructed to eat 20 g
of carbohydrates. Glycemic status was evaluated after
30 min. If hyperglycemia (i.e. blood glucose >15 mmol/l)
would persist, participants were instructed to inject an-
other 2 units of insulin; if hypoglycemia would persist,
participants additionally had to eat 20 g of carbohydrates
[2]. Blood and 24-hour urine sampling was used to per-
form routine measures [4]. Hypertension was present
when systolic blood pressure was >140 mmHg and/or dia-
stolic blood pressure of was >90 mmHg or when anti-
hypertensive drugs were used, and was an exclusion criter-
ion for control participants. Life-time severe hypoglycemic
events were self-reported according to DCCT criteria. The
Center for Epidemiological Studies scale for Depression
(CES-D) had to be filled out at home. IQ was estimated
using the Dutch version of the National Adult Reading
Test. This study was approved by the Medical Ethics
Committee of the VU University Medical Center, in
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informed consent was obtained from every participant.
Vascular ultrasound assessment
On the morning of the ultrasound, participants were
instructed to have a standardised breakfast, not including
eggs, coffee, tea or orange juice and not to smoke. Ultra-
sound of the right common carotid artery was performed
by a single blinded research assistant, after participants
rested for 10 minutes in the supine position. An arterial
wall B-mode ultrasound imager with a 7.5 MHz linear-
array transducer (Esaote, Maastricht, The Netherlands)
was used. Measurement site was approximately 10 mm
from the carotid bulb. The exact measurement site on the
artery was determined in the B-mode, in a region free of
plaque with a clearly identified double-line pattern.
Then data acquisition was performed in the M-mode for
4 seconds, triggered by the R-top of the ECG. Offline, 2
components of subclinical macrovascular disease, i.e. cIMT
and carotid Distensibility (cD) were calculated using vessel
wall movement detection software (Wall Track System, Pie
Medical, Maastricht, The Netherlands). For each subject,
to calculate the cIMT, 3 measurements were selected. A
measurement was selected if the standard deviation of the
mean diameter of the lumen was less than 1% of that mean
diameter. For reproducibility purposes, measurements of
15 randomly selected participants were assessed a second
time after a year by the same assistant. This yielded an ab-
solute mean difference in cIMT of 0.0128 mm, with an in-
terclass correlation coefficient κ of 0.985 with a 95%
confidence interval: 0.955 – 0.995.
Additionally, arterial stiffness was estimated by meas-
uring the relative changes in lumen area for a given
change in pressure (ΔA/AxΔP [kPa−1]). The higher the
change in lumen area of the carotid artery the more
flexible the arterial wall, therefore, a low cD value is
associated with increased arterial stiffness. As this is
a functional measure, it is more sensitive to intra-
personal circumstances and levels of cD can fluctuate
within each participant. To prevent selection bias, it
was decided to include cD values of all measurements
made for each participant.
Neuropsychological assessment
As described previously, all participants underwent a de-
tailed neuropsychological assessment, which showed
poorer performance in T1DM patients on general cogni-
tive ability, information processing speed, and attention
[2,4]. These will be further analysed in this study.
White matter tract integrity
Using Magnetic Resonance (MRI) Diffusion Tensor
Imaging, white matter tract integrity was assessed as
previously described [3]. Most prominent changes andcorrelations with cognition were seen in the bilateral
corticospinal and inferior fronto-occipital tracts, which
will be used in this study [3].
Resting-state functional MRI
A detailed description of acquisition and analysis of
resting-state functional MRI (fMRI) can be found else-
where [4]. Increased resting-state fMRI functional con-
nectivity was found in sensorimotor and secondary
visual networks in patients without proliferative retin-
opathy, with decreased connectivity in their counter-
parts with this complication [4]. Effects of subclinical
macroangiopathy on connectivity in these network will
be examined.
Statistical analysis
Demographic, anthropometric and medical variables
were analysed using One-Way ANOVA with Bonferroni
correction, Student’s t-test, Kurskal-Wallis test or chi-
square, whether appropriate. Carotid IMT between pa-
tients and controls was compared using a MANCOVA
corrected for age, sex, systolic blood pressure and mul-
tiple comparisons (Bonferroni). First, interaction terms
between group (all patients vs. controls) and subclinical
macroangiopathy were tested for brain parameters. In case
of a significant interaction effect, the association between
those brain variables and subclinical macroangiopathy was
analyzed in all patients and controls separately. In the ab-
sence of an interaction effect, these associations were cal-
culated in a pooled analysis in all participants. For the
pooled analysis, all associations were studied using linear
regression, corrected for age, sex and systolic blood pres-
sure and additionally for HbA1c, current smoking status
and depressive symptomatology. Next, interactions of sub-
clinical macroangiopathy and proliferative retinopathy on
brain parameters were tested in all T1DM patients. In case
of significant interaction terms, groups were analyzed sep-
arately. Linear regression was again used to determine as-
sociations between subclinical macroangiopathy and brain
variables. These analyses in T1DM patients alone were
corrected for age, sex and systolic blood pressure, diabetes
duration, HbA1c, current smoking status and depressive
symptomatology. For all tests a P-value of <0.05 to indi-
cate statistical significance was used. All analysis were per-
formed using IBM-SPSS 20 (Chicago, IL, USA).
Results
Participant characteristics
Echography of 1 control and 2 patients without micro-
vascular complications did not result in reliable cIMT or
cD values. Thus, they were excluded from the analyses.
Table 1 lists baseline characteristics of study participants.
T1DM patients with proliferative retinopathy were old-
est and reported most depressive symptoms relative to
Table 1 Baseline characteristics
T1DM with proliferative retinopathy T1DM without proliferative retinopathy Controls Overall P-value
N 51 51 50 -
Age (years) 44.5 ± 7.1*# 38.1 ± 9.3 36.7 ± 11.4 <0.001
Sex male/female 21/30 20/33 20/31 0.978
Estimated IQa 110.2 ± 13.4 106.8 ± 11.3 108.5 ± 12.0 0.388
Depressive symptomsb 8.0 (0 – 42)*# 5.0 (0 – 31) 4.5 (0 – 37) 0.008
BMI (kg/m2) 25.6 ± 4.1 24.8 ± 3.6 24.1 ± 3.5 0.126
Height (meters) 1.73 ± 0.1 1.75 ± 0.1 1.76 ± 0.1 0.300
Current smoker (%) 6 (11.8) 10 (19.6) 11 (22.0) 0.347
HbA1c (mmol/mol) 64.7 ± 14.1* 61.7 ± 9.8* 34.3 ± 2.6 <0.001
HbA1c (%) 8.1 ± 1.3* 7.8 ± 0.9* 5.3 ± 0.2 <0.001
Total cholesterol (mmol/l) 4.5 ± 0.7 4.7 ± 0.7 4.5 ± 0.9 0.276
HDL cholesterol (mmol/l) 1.8 ± 0.5* 1.8 ± 0.5* 1.5 ± 0.4 0.001
LDL cholesterol (mmol/l) 2.4 ± 0.6 2.5 ± 0.6 2.5 ± 0.8 0.686
Systolic BP (mmHg) 133.6 ± 17.3* 129.0 ± 14.9 123.9 ± 11.4 0.005
Diastolic BP (mmHg) 76.0 ± 8.7 78.1 ± 9.7 77.1 ± 7.2 0.488
Hypertension (%)c 33 (64.7) 12 (23.5) - <0.001
ACR (mg/mmol) 0.9 (0 – 33.2) 0.4 (0 – 3.19) - 0.005
Diabetes duration (years) 34.3 ± 7.8 21.8 ± 9.4 - <0.001
Diabetes onset age (years) 10.2 ± 7.2 16.3 ± 9.7 - 0.001
Early onset diabetes (%)d 18 (35.3) 10 (19.6) 0.120
BG before echo (mmol/l) 9.2 ± 4.0 8.9 ± 3.2 - 0.766
Severe hypoglycemiae 2.0 (0 – 40) 2.0 (0 – 50) - 0.770
Neuropathy (%)f 25 (49) - - -
Microalbuminuria (%)g 14 (27.5) - - -
Data are represented as mean with standard deviation, median with min/max or absolute numbers with percentage between parenthesis. BMI: body mass index;
BP: blood pressure; ACR: albumin:creatinine ratio; BG: blood glucose.
*Statistically different from controls.
#Statistically different from patients without proliferative retinopathy.
aEstimated IQ was measured using the Dutch version of the National Adult Reading Test (NART).
bDepressive symptoms were self-reported using the Center for Epidemiological Studies scale for Depression (CES-D).
cHypertension was defined as a systolic blood pressure >140 mmHg, a diastolic blood pressure of >90, or the use of antihypertensive drugs.
dEarly diabetes onset was defined as a onset before 7 years of age.
eSevere hypoglycaemic events were self-reported during lifetime according to DCCT guidelines.
fPeripheral neuropathy status was collected from the medical records, based on data from the annual check-up patients receive, or, if not available,
was self-reported.
gMicroalbuminuria was defined as an albumin-to-creatinine ratio >2.5 mg/mmol for men and >3.5 mg/mmol for women.
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blood pressure relative to controls. Patients with, as
compared to those without proliferative retinopathy, had
longer disease duration, earlier onset age, more often
hypertension and increased albumin:creatinine ratio (all
P < 0.05).
Subclinical macroangiopathy
Carotid IMT, after correction for age, sex, systolic
blood pressure and multiple comparisons, was border-
line increased in all T1DM patients versus controls
(P = 0.071; Figure 1A). No differences in cD were found
between the 2 groups (Figure 1B). Patients with prolif-
erative retinopathy showed the largest increase in cIMTand the largsest decrease in cD, although not statisti-
cally significant.
Associations between vascular and cerebral findings
There were no significant interaction effects between
cIMT or cD and group (all T1DM patients and controls)
for cognition, white matter integrity or functional con-
nectivity (all Pinteraction > 0.05). Thus, all participants
were used in a pooled analysis. Increased carotid intima
media thickness was associated with white matter integ-
rity of the right inferior fronto-occipital tract (β = −0.206
P = 0.027) and borderline associated with decreased vis-
ual network functional connectivity (β = −0.176 P =
0.064), after correction for age, gender and systolic blood












































Figure 1 Bar chart of mean cIMT (panel A) and cD (panel B) values with standard deviation per group. T1DM: all type 1 diabetes patients;
pDRP-: patients without proliferative retinopathy; pDRP+: patients with proliferative retinopathy; IMT: intima media thickness.
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correction for current smoking, depressive symptom-
atology and HbA1c (β = −0.198 P = 0.041; and β = −0.195
P = 0.046, respectively).
Interaction between subclinical macroangiopathy and
proliferative retinopathy
Next, the possible interaction between subclinical macro-
angiopathy and proliferative retinopathy was assessed in
all T1DM patients. For general cognitive ability, informa-
tion processing speed and attention, there were statisti-
cally significant interactions between cIMT, but not cD,
and proliferative retinopathy, corrected for age, gender
and systolic blood pressure (all Pinteraction < 0.05). After
additional correction for diabetes duration, current smok-
ing, depressive symptomatology, and HbA1c the results of
the interaction analyses were similar (all Pinteraction < 0.05).
There were no significant interaction terms for white mat-
ter integrity or functional connectivity. There were no as-
sociations between cIMT and cognitive parameters in
patients with proliferative retinopathy (all P > 0.05). Con-
trary, in T1DM patients without clinically manifest micro-
vascular complications, there were significant associations
between increased cIMT and poorer general cognitive
ability (β = −0.334; P = 0.018; Figure 2A), information pro-
cessing speed (β = −0.361; P = 0.010; Figure 2B) and atten-
tion (β = −0.394; P = 0.005; Figure 2C). These results were,Figure 2 Dot plots of relations between cIMT and general cognitive a
attention (panel C) in patients with (black triangles) and without (gre
without proliferative retinopathy were statistically significant. After correctio
attention in patient without proliferative retinopathy remained statisticallygiven the smaller sample size, uncorrected for confound-
ing. After correction for confounding factors (age, gender,
systolic blood pressure, diabetes duration, current smok-
ing, depressive symptomatology, and HbA1c) the associ-
ation between increased cIMT and poorer attentional
functioning remained significant (β = −0.388; P = 0.028).
Discussion
Both measures of subclinical macroangiopathy were not
statistically different between patients and controls. In
all participants, a greater cIMT was associated with
lower white matter tract integrity and functional con-
nectivity. For cognition, an interaction between cIMT
and proliferative retinopathy was noted. In patients with-
out, but not with proliferative retinopathy, cIMT was
negatively associated with cognition. Carotid stiffness
was not associated with brain parameters in this study.
Subclinical macroangiopathy in T1DM
In this study there was no difference in either cIMT or
cD between T1DM patients, irrespective of micro-
vascular complication status, and controls. The differ-
ence between all patients and controls trended to be
statistically significant. These findings are contrary to
previous studies, which did observe increased cIMT in
T1DM patients relative to controls [8,9]. This could
have been due to the lower sample size of this studybility (panel A), information processing speed (panel B) and
y circles) proliferative retinopathy. Only associations in patients
n for multiple confounders the association between cIMT and
significant.
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this study were lower than in the other studies, and
levels of albuminuria were also lower in this study.
Given the associations between higher HbA1c levels
and albuminuria [13], this may explain the differences
between studies.
Our negative findings with respect to cIMT between
groups are in line with a recently published study in
young adults with uncomplicated T1DM with a mean
disease duration of 6 years [14]. In that study circulat-
ing levels of soluble endothelial CD146 were increased
in patients relative to controls and CD146 better differ-
entiated between patients and controls. This suggests
that CD146 may be a more sensitive marker for early
cardiovascular disease than cIMT, although this is still
speculative. The relationship between circulating
CD146 and cerebral parameters, and its additive value
to measures of cIMT and cD, is unknown. CD146
nervous system knockout mice displayed altered loco-
motor activity compared with their wildtype counter-
parts [15]. Future studies should determine the effect
of circulating and central levels of soluble CD146 on
cognition and cerebral structure/functioning in human
T1DM.
Based on previous observations, including those from
the DCCT/EDIC study, that showed that albuminuria
was among the predictors of progression in cIMT at
12 years of post-trial follow-up [13], we hypothesized
the existence of an interaction between microangiopa-
thy (mainly proliferative retinopathy in our population)
and subclinical macroangiopathy. Accordingly, we ex-
pected that the co-existence of macro- and microangi-
opathy in T1DM patients would have the greatest
impact on cognitive function and/or brain correlates.
Instead, in our study population, a greater cIMT only
influences brain variables in patients without micro-
vascular complications. The results of this study are in
line with the findings from the DCCT/EDIC study, that
also showed that microvascular complications were a
stronger predictor of cognitive decline in T1DM pa-
tients than cIMT [5].
Associations with brain parameters
A novel finding is that increased cIMT is related to
lower white matter integrity and functional connectivity,
i.e. neuronal communication, in certain brain regions.
These findings seem to hold true both for those with
and without T1MD. As this association is not disease
specific it may well be related to aging, as both increased
cIMT and loss of white matter integrity are seen with
aging [13,16,17]. There were no interaction effects of
subclinical macroangiopathy and proliferative retinop-
athy regarding these brain parameters. This may indicate
that increased subclinical atherosclerosis in larger vesselshas an effect on communication and structure within
brain regions, but that retinal angiopathy has no overrul-
ing effect, such as found for cognitive performance. Per-
formance on cognitive functions which were assessed
in this study, rely on the integration of brain activity
from multiple different brain regions, which all have to
function properly [18]. As such it may be speculated
that proliferative retinopathy, which seems part of gen-
eralized microangiopathy as measured in the brain and
finger [19], has consequences for the functioning of
one or more brain regions and possibly also for the in-
tegration of activity, and thus for cognitive perform-
ance. Hence, the effect of subclinical atherosclerosis is
overruled when proliferative retinopathy is present. On
the other hand, white matter integrity and functional
connectivity assessed here were more localized in
specific brain regions. As they do not rely on many
different cerebral areas or integration of functionality,
the effect of disrupted microvasculature may be less
pronounced.
In addition to measures of cognition, brain func-
tioning and white matter integrity, the relationship
between subclinical macroangiopathy and parameters
of cerebral blood flow would have been of interest. A
recently published [15O]H2O positron emission tom-
ography (PET) study showed decreased blood flow in
adult patients with asymptomatic T1DM relative to
controls [20]. These patients were free of clinically
manifest macroangiopathy, but carotid ultrasound
was not available. Unfortunately, measurements of
cerebral blood flow were not included in the current
study.
In this study no effects were found for carotid distensi-
bility. Contrary, a previous case–control study showed
that in middle-aged T1DM patients without or with mild
microvascular complications (mostly background retin-
opathy), increased aortic stiffness was related to lower
total brain white matter volume and increased preva-
lence of white matter hyperintensities, i.e. ischemic brain
damage [21,22]. Similarly, in elderly with type 2 diabetes
(T2DM), both higher subclinical carotid atherosclerotic
macroangiopathy and carotid-femoral pulse wave vel-
ocity were related to silent cerebral infarctions and white
matter hyperintensities respectively. These associations
were independent of confounding factors, including age,
sex, lipid profile and blood pressure [10,23]. The results
of the current study, together with the results of the
previously published studies support the notion that
subclinical macroangiopathy is related to cognitive dec-
rements and structural and functional brain deficits that
are commonly observed in patients with either T1DM
or T2DM. However, the effect sizes seem to be small to
moderate, which may indicate that other factors, such as
microvascular complications, may be more prominent
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in diabetes.
The effects sizes of the observed associations were
small to moderate, indicating a relatively moderate con-
tribution of cIMT in T1DM-related cognitive dysfunc-
tion. From this study it cannot be determined why
T1DM-related cerebral compromise in patients with
proliferative retinopathy was not exacerbated by mea-
sures of subclinical macroangiopathy. However, based
on our findings, one may speculate that early cognitive
changes, i.e. before microvascular complications are
present, may be in part mediated by increased cIMT, but
that once microangiopathy has developed T1DM-related
cerebral compromise, the effects of subclinical macro-
vascular disease is overruled. This differential effect of
macro- and microvascular disease on CNS function and
structure requires further study.
Limitations
The cross-sectional nature of this study pertains us to
draw causal conclusions. Other limitations may include
that fact that our patient with proliferative retinopathy
had longer disease duration and earlier disease onset age
than their counterparts without complications, both of
which could constitute a confounder. Therefore, we cor-
rected for diabetes duration in the analyses in T1DM pa-
tients. Additional correction for diabetes onset age is not
possible due to co-linearity between the two variables.
But removing diabetes duration from the analyses and
adding diabetes onset age yielded similar results. This
may indicate that our findings are independent of dis-
ease duration and diabetes onset age. Furthermore, an
early disease onset age (i.e. <7 years of age) has been
hypothesised to have more adverse effects on the brain
than an onset later in life [24]. In this sample early age
of onset had no effect on the associations of subclinical
macroangiopathy and cerebral compromise. Here, we
measured cIMT and cD of the common carotid artery,
as it has been found a prognostic measure of cardiovas-
cular disease [16,25-27]. However, the internal carotid
artery provides the main blood supply to the brain,
whereas the common carotid artery also supplies the ex-
ternal carotid artery. Additionally examining the rela-
tionship between cIMT and cD of the internal carotid
artery and brain parameters would have been of interest.
Indeed, the Framingham study found stronger associa-
tions between internal carotid IMT and brain parameters
than between common carotid IMT and brain measures
[11]. Future studies will have to determine this relation-
ship in T1DM patients. Also plaque in the internal ca-
rotid artery could not be taken into account in this
study. Strength of this study includes the relatively large
number of well-characterised T1DM patients, especially
regarding neuroradiological measurements, as well asthe presence of a control group, and the combination of
extensive neuropsychological assessment with neurora-
diological measurements.Conclusions
In conclusion, in T1DM patients without, contrary to pa-
tients with proliferative retinopathy, cIMT as marker of
subclinical atherosclerotic disease, but not cD, as marker of
arterial stiffness, was related to poorer performance in cog-
nitive domains. Furthermore, increased cIMT, but not cD,
was related to decreased functional connectivity and white
matter integrity. The underlying mechanisms contributing
to these differential findings remain to be determined, but
it might be that the consequences of microangiopathy on
the diabetes brain overrule the more subtle effects of in-
cipient macrovascular disease.
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